+24
Tactus Therapy Solutions
For stroke and brain injury survivors with aphasia or apraxia, and the speech-language pathologists (SLPs) who treat them.
For stroke and brain injury survivors with aphasia or apraxia, and the speech-language pathologists (SLPs) who treat them.
Providing digital, evidence-based speech therapy tools for stroke survivors and clinicians to replace traditional physical rehabilitation aids.
Target audience
Portfolio
Free 7Last updated
Advanced Comprehension Therapy
v3.02
2.1y ago
Primary focus
Digital speech-language pathology and stroke rehabilitation tools
Scale
studio
Target audience
Stroke and brain injury survivors with aphasia or apraxia, and the speech-language pathologists (SLPs) who treat them.
Released 6 updates across the portfolio in the last 6 months with over 70% of the catalog currently active, indicating consistent maintenance of clinical tools.
27 apps analysed
One-time pricing model avoids subscription fatigue
Take your aphasia therapy to the next level with 4 evidence-based advanced apps
Take your aphasia therapy to the next level with 4 evidence-based advanced apps
Distributed across 13 markets, strongest in Americas.
Based on 6 of 27 apps with localized market data — more coverage rolling in as scans complete · last scanned .
3
Positive apps
1
Neutral / mixed
0
Negative apps
83/100
Avg sentiment score
This is the only direct competitor in the professional clinical speech therapy space with a high-volume, active user base and frequent clinical updates.
Strategic outlook coming soon.
What fed this analysis
Shares the speech therapy category but focuses on articulation and phonology rather than sentence-level comprehension.
Targets the same functional goal of sentence construction and language processing, though with a more casual, gamified approach.
Focuses on cognitive training and brain health, serving an overlapping audience interested in neurological recovery and maintenance.
High-velocity release cadence indicates a pivot toward broader cognitive wellness, encroaching on the target's therapeutic space.
Maintains an extremely high release frequency, signaling a focus on rapid feature iteration and user retention.
